NS
URGN icon

NBC Securities’s UroGen Pharma URGN Stock Holding History

NBC Securities’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-816
Closed -$16.3K – 2935
2025
Q3 		$16.3K Buy
816
+169
+26% +$3.04K ﹤0.01% 1849
2025
Q2 		$8K Hold
647
– – ﹤0.01% 2014
2025
Q1 		$7K Buy
+647
New +$6.9K ﹤0.01% 1815
2024
Q4 		– Sell
-647
Closed -$8K – 2035
2024
Q3 		$8K Hold
647
– – ﹤0.01% 1811
2024
Q2 		$10K Buy
647
+210
+48% +$2.99K ﹤0.01% 1694
2024
Q1 		$6K Buy
+437
New +$7.14K ﹤0.01% 1839

Other funds holding URGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

NBC Securities's URGN Position: Q4 2025 in Review

NBC Securities sold out of UroGen Pharma (URGN) in Q4 2025, closing a stake of 816 shares — an estimated $16.3K sold.

NBC Securities first reported a position in URGN in Q1 2024 and held it in 6 quarters. The position peaked at $16.3K in Q3 2025. 167 funds tracked by Wall St. Rank hold URGN as of Q4 2025.

  • NBC Securities reported no remaining UroGen Pharma position as of Q4 2025 after selling out during the quarter.
  • NBC Securities sold 816 UroGen Pharma shares in Q4 2025, an estimated $16.3K.
  • NBC Securities first reported a position in UroGen Pharma in Q1 2024 and held it in 6 quarters.
  • NBC Securities's UroGen Pharma position peaked at $16.3K in Q3 2025.
  • 167 funds tracked by Wall St. Rank held UroGen Pharma as of Q4 2025.

Based on NBC Securities's 13F filing for Q4 2025, filed 29 Jan 2026.